You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Phase 1/2 clinical trial

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial (Lutetium Lu 177 JH020002 Injection)

Not yet recruiting
  • Prostate Cancer
  • Lutetium Lu 177 JH020002 Injection
  • (no location specified)
Nov 14, 2023

Solid Tumor Trial in Birtinya (IBI130)

Not yet recruiting
  • Solid Tumor
  • Birtinya, Queensland, Australia
    Sunshine Coast University
Jun 19, 2023

Advanced Prostate Cancer Trial (HRS-4357 injection)

Not yet recruiting
  • Advanced Prostate Cancer
  • HRS-4357 injection
  • (no location specified)
Aug 16, 2023

Prostate Cancer, mCRPC Trial in Seoul (Lu-177-DGUL, Ga-68-NGUL)

Recruiting
  • Prostate Cancer
  • mCRPC
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Sep 22, 2022

Small Cell Lung Cancer Extensive Stage Trial (quaratusugene ozeplasmid, atezolizumab)

Not yet recruiting
  • Small Cell Lung Cancer Extensive Stage
  • quaratusugene ozeplasmid
  • atezolizumab
  • (no location specified)
Jan 19, 2023

Acute on Chronic Hepatic Failure, Liver Failure, Hepatitis Trial (HepaCure)

Not yet recruiting
  • Acute on Chronic Hepatic Failure
  • +2 more
  • HepaCure
  • (no location specified)
Aug 4, 2023

Double Vaccinated for COVID-19 (For Phase 1 of the Study), Acute Respiratory Syndrome Coronavirus 2 (For Phase 2 Exploratory

Recruiting
  • Double Vaccinated for COVID-19 (For Phase 1 of the Study)
  • Acute Respiratory Syndrome Coronavirus 2 (For Phase 2 Exploratory Group)
  • COVAC-2
  • Saline Placebo
  • Burlington, Ontario, Canada
  • +2 more
Aug 24, 2022

Breast Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Portland, Suwon (AB-201, Cyclophosphamide,

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Portland, Oregon
  • +1 more
Jan 12, 2023

Breast Cancer, Ovarian Cancer, Breast Tumors Trial in Dnipro, Kyiv (Axitinib)

Enrolling by invitation
  • Breast Cancer
  • +7 more
  • Dnipro, Ukraine
  • +1 more
Jun 17, 2023

Chikungunya Virus Infection Trial (VLA1553 full dose, VLA1553 half dose, Control)

Not yet recruiting
  • Chikungunya Virus Infection
  • VLA1553 full dose
  • +2 more
  • (no location specified)
Oct 24, 2023

Disfigurement From Photographs of Neurofibromatosis Type 1

Completed
  • Neurofibromatosis 1
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Solid Tumor Trial (CP-506, Carboplatin, Immune checkpoint inhibitor)

    Not yet recruiting
    • Unspecified Adult Solid Tumor, Protocol Specific
    • (no location specified)
    Jun 23, 2022

    NSCLC Trial (Phase I - Mirdametinib - Level 1, Phase II - Mirdametinib, Phase I - Mirdametinib - Level 2)

    Not yet recruiting
    • Non-Small Cell Lung Cancer
    • Phase I - Mirdametinib - Level 1
    • +4 more
    • (no location specified)
    Jul 7, 2023

    Krabbe Disease Trial in Ann Arbor (FBX-101)

    Recruiting
    • Krabbe Disease
    • FBX-101
    • Ann Arbor, Michigan
      University of Michigan Hospitals - Michigan Medicine
    Aug 24, 2022

    Atopic Dermatitis Trial in Bexley (Part 1 ADX-629 (Open-label))

    Not yet recruiting
    • Atopic Dermatitis
    • Part 1 ADX-629 (Open-label)
    • Bexley, Ohio
      Bexley Dermatology Research
    Feb 6, 2023

    B-cell Lymphoma, Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial (BN301)

    Not yet recruiting
    • B-cell Lymphoma
    • +4 more
    • (no location specified)
    Nov 9, 2022

    Safety, Tolerability, Pharmacokinetics Trial in Karachi (RHN-001 (one tablet 750mg), RHN-001 (750mg * 2 Tablets))

    Completed
    • Safety
    • +2 more
    • RHN-001 (one tablet 750mg)
    • RHN-001 (750mg * 2 Tablets)
    • Karachi, Sindh, Pakistan
      Center for Bioequivalence Studies and clinical research (CBSCR),
    Apr 26, 2023

    Advanced Cancer Trial in South Brisbane, Bedford Park, Melbourne (AWT020)

    Recruiting
    • Advanced Cancer
    • AWT020
    • South Brisbane, Queensland, Australia
    • +2 more
    Oct 18, 2023

    Osteoarthrosis Trial in Seoul (E1K 1,200 ?/joint, E1K 2,400 ?/joint, )

    Recruiting
    • Osteoarthrosis
    • E1K 1,200 ㎍/joint
    • +2 more
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Jan 15, 2023

    ALS Trial ([11C]CPPC PET ligand)

    Not yet recruiting
    • ALS
    • [11C]CPPC PET ligand
    • (no location specified)
    Jan 9, 2023

    MPS I, MPS1-S, MPS1-HS Trial in Porto Alegre, London, Salford (SIG-005 (hIDUA Producing Spheres))

    Withdrawn
    • MPS I
    • +2 more
    • SIG-005 (hIDUA Producing Spheres)
    • Porto Alegre, Brazil
    • +2 more
    Dec 16, 2022

    Beta-Thalassemia Trial in China (BRL-101)

    Recruiting
    • Beta-Thalassemia
    • Guangzhou, Guangdong, China
    • +3 more
    Nov 7, 2022

    COVID-19, SARS-CoV-2 Infection Trial (SCTV01E-2, SCTV01E)

    Not yet recruiting
    • COVID-19
    • SARS-CoV-2 Infection
    • SCTV01E-2
    • SCTV01E
    • (no location specified)
    Jul 4, 2023

    Hamstring Injury Trial in Pittsburgh (Losartan, )

    Recruiting
    • Hamstring Injury
    • Pittsburgh, Pennsylvania
      University of Pittsburgh
    Dec 14, 2022

    Metastatic Breast Cancer Trial in Pompano Beach, Caracas (ConvitVax)

    Not yet recruiting
    • Metastatic Breast Cancer
    • ConvitVax
    • Pompano Beach, Florida
    • +2 more
    Aug 28, 2023